Wolf SF - Search Results

1

Construction and characterization of retroviral vectors expressing biologically active human interleukin-12.

Zitvogel L, Tahara H, Cai Q, Storkus WJ, Muller G, Wolf SF, Gately M, Robbins PD, Lotze MT. Zitvogel L, et al. Among authors: wolf sf. Hum Gene Ther. 1994 Dec;5(12):1493-506. doi: 10.1089/hum.1994.5.12-1493. Hum Gene Ther. 1994. PMID: 7711142

2

Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapy.

Pappo I, Tahara H, Robbins PD, Gately MK, Wolf SF, Barnea A, Lotze MT. Pappo I, et al. Among authors: wolf sf. J Surg Res. 1995 Feb;58(2):218-26. doi: 10.1006/jsre.1995.1034. J Surg Res. 1995. PMID: 7861776

3

Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.

Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Storkus WJ, et al. Nastala CL, et al. Among authors: wolf sf. J Immunol. 1994 Aug 15;153(4):1697-706. J Immunol. 1994. PMID: 7913943

4

Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.

Tahara H, Zeh HJ 3rd, Storkus WJ, Pappo I, Watkins SC, Gubler U, Wolf SF, Robbins PD, Lotze MT. Tahara H, et al. Among authors: wolf sf. Cancer Res. 1994 Jan 1;54(1):182-9. Cancer Res. 1994. PMID: 7903204

5

Interleukin 12 at the site of disease in tuberculosis.

Zhang M, Gately MK, Wang E, Gong J, Wolf SF, Lu S, Modlin RL, Barnes PF. Zhang M, et al. Among authors: wolf sf. J Clin Invest. 1994 Apr;93(4):1733-9. doi: 10.1172/JCI117157. J Clin Invest. 1994. PMID: 7909320 Free PMC article.

6

IL-12 regulates T helper type 1 cytokine responses in human infectious disease.

Sieling PA, Wang XH, Gately MK, Oliveros JL, McHugh T, Barnes PF, Wolf SF, Golkar L, Yamamura M, Yogi Y, Uyemura K, Rea TH, Modlin RL. Sieling PA, et al. Among authors: wolf sf. J Immunol. 1994 Oct 15;153(8):3639-47. J Immunol. 1994. PMID: 7930584

7

Antitumor and antimetastatic activity of interleukin 12 against murine tumors.

Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF, Gately MK. Brunda MJ, et al. Among authors: wolf sf. J Exp Med. 1993 Oct 1;178(4):1223-30. doi: 10.1084/jem.178.4.1223. J Exp Med. 1993. PMID: 8104230 Free PMC article.

8

Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells.

Perussia B, Chan SH, D'Andrea A, Tsuji K, Santoli D, Pospisil M, Young D, Wolf SF, Trinchieri G. Perussia B, et al. Among authors: wolf sf. J Immunol. 1992 Dec 1;149(11):3495-502. J Immunol. 1992. PMID: 1358972

9

Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.

Chehimi J, Valiante NM, D'Andrea A, Rengaraju M, Rosado Z, Kobayashi M, Perussia B, Wolf SF, Starr SE, Trinchieri G. Chehimi J, et al. Among authors: wolf sf. Eur J Immunol. 1993 Aug;23(8):1826-30. doi: 10.1002/eji.1830230814. Eur J Immunol. 1993. PMID: 8102101

10

Modulation of perforin and granzyme messenger RNA expression in human natural killer cells.

Salcedo TW, Azzoni L, Wolf SF, Perussia B. Salcedo TW, et al. Among authors: wolf sf. J Immunol. 1993 Sep 1;151(5):2511-20. J Immunol. 1993. PMID: 8103068

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters